02/20/19
Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
02/15/19
Acorda Therapeutics Inc ACOR announced fourth quarter 2018 earnings per share of 45 cents significantly beating the Zacks Consensus Estimate of a loss of 60 cents However the figure declined from the year ago earnings of 61 cents Acorda generated total revenues of 69 1 million in
02/15/19
Image source The Motley Fool Acorda Therapeutics NASDAQ ACOR Q4 2018 Earnings Conference Call Feb 14 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator
02/15/19
Acorda Therapeutics ACOR came out with quarterly earnings of 0 45 per share beating the Zacks Consensus Estimate of a loss of 0 60 per share This compares to earnings of 0 61 per share a year ago These figures are adjusted for non recurring items This quarterly report represents
02/06/19
Array BioPharma Inc ARRY was a big mover last session as the company saw its shares rise nearly 11 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above
01/31/19
The Medical group has plenty of great stocks but investors should always be looking for companies that are outperforming their peers Acorda Therapeutics ACOR is a stock that can certainly grab the attention of many investors but do its recent returns compare favorably to the sector as a
01/24/19
Vertex Pharmaceuticals VRTX announced the termination of Ian Smith from the post of chief operating officer COO and interim chief financial officer CFO with immediate effect Smith served the company in several leading positions for more than 17 years The company stated that
ACOR - Acorda Therapeutics